Insider filing · CRSP
James R. Kasinger
General Counsel and Secretary
profile →
CRISPR Therapeutics AG
CRSP · Healthcare · 39 filings in 24 months
ticker →
James R. Kasinger sold $619K of CRISPR Therapeutics AG (CRSP)
Executed Feb 18 2025, disclosed Feb 19 2025, 1 day later.
Value, as filed
$619K
11,542 sh across 2 lots
Executed
Feb 18 2025
the trade date, as filed
Disclosed
Feb 19 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JKJames R. Kasinger (General Counsel and Secretary) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in CRISPR Therapeutics AG (CRSP). The largest single filing was $626K of CRSP (10,400 sh × $60.24, as filed), executed Sep 22.
The name
CRSPHealthcare · CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered R…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by James R. Kasinger in CRSP
CRSPSALE
CRISPR Therapeutics AG
$119K1,990 sh × $60.04
Exec Oct 6
Filed Oct 8 · 5:35 PM ET CRSPSALE CRISPR Therapeutics AG $626K
10,400 sh × $60.24
Exec Sep 22
Filed Sep 24 · 5:35 PM ET CRSPSALE CRISPR Therapeutics AG $149K
3,182 sh × $46.78
Exec Mar 23
Filed Mar 24 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG $166K
3,450 sh × $48.26
Exec Mar 16
Filed Mar 17 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG $148K
2,800 sh × $52.80
Exec Mar 11
Filed Mar 12 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG $111K
2,112 sh × $52.58
Exec Feb 19
Filed Feb 20 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG $131K
3,185 sh × $41.23
Exec Mar 21 2025
Filed Mar 24 2025 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG $121K
2,850 sh × $42.42
Exec Mar 11 2025
Filed Mar 12 2025 · 5:30 PM ET